Autek China Inc (300595) - Total Assets
Based on the latest financial reports, Autek China Inc (300595) holds total assets worth CN¥6.40 Billion CNY (≈ $936.80 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Autek China Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Autek China Inc - Total Assets Trend (2012–2025)
This chart illustrates how Autek China Inc's total assets have evolved over time, based on quarterly financial data. Check Autek China Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Autek China Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Autek China Inc's total assets of CN¥6.40 Billion consist of 60.3% current assets and 39.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 13.5% |
| Accounts Receivable | CN¥362.88 Million | 5.8% |
| Inventory | CN¥172.11 Million | 2.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥83.79 Million | 1.3% |
| Goodwill | CN¥884.02 Million | 14.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Autek China Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Autek China Inc.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Autek China Inc's current assets represent 60.3% of total assets in 2025, a decrease from 92.6% in 2012.
- Cash Position: Cash and equivalents constituted 13.5% of total assets in 2025, down from 22.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 14.0% of total assets.
Autek China Inc Competitors by Total Assets
Key competitors of Autek China Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Tarsons Products Limited
NSE:TARSONS
|
India | Rs11.64 Billion |
|
SciVision Biotech Inc
TW:1786
|
Taiwan | NT$2.67 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
Autek China Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.84 | 5.81 | 6.41 |
| Quick Ratio | 5.58 | 5.57 | 6.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.36 Billion | CN¥3.32 Billion | CN¥1.46 Billion |
Autek China Inc - Advanced Valuation Insights
This section examines the relationship between Autek China Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.51 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 4.4% |
| Total Assets | CN¥6.30 Billion |
| Market Capitalization | $1.44 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Autek China Inc's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Autek China Inc's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Autek China Inc (2012–2025)
The table below shows the annual total assets of Autek China Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.30 Billion ≈ $921.68 Million |
+4.44% |
| 2024-12-31 | CN¥6.03 Billion ≈ $882.51 Million |
+9.28% |
| 2023-12-31 | CN¥5.52 Billion ≈ $807.59 Million |
+7.82% |
| 2022-12-31 | CN¥5.12 Billion ≈ $749.00 Million |
+72.20% |
| 2021-12-31 | CN¥2.97 Billion ≈ $434.96 Million |
+34.32% |
| 2020-12-31 | CN¥2.21 Billion ≈ $323.82 Million |
+37.79% |
| 2019-12-31 | CN¥1.61 Billion ≈ $235.01 Million |
+30.81% |
| 2018-12-31 | CN¥1.23 Billion ≈ $179.65 Million |
+33.08% |
| 2017-12-31 | CN¥922.57 Million ≈ $135.00 Million |
+158.06% |
| 2016-12-31 | CN¥357.50 Million ≈ $52.31 Million |
+20.45% |
| 2015-12-31 | CN¥296.80 Million ≈ $43.43 Million |
+41.21% |
| 2014-12-31 | CN¥210.19 Million ≈ $30.76 Million |
+29.02% |
| 2013-12-31 | CN¥162.92 Million ≈ $23.84 Million |
+40.29% |
| 2012-12-31 | CN¥116.13 Million ≈ $16.99 Million |
-- |
About Autek China Inc
Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It a… Read more